Home › Type 1 Diabetes › NCT06384911
InvesT1D: Promoting Adolescent Investment in Diabetes Care
Who can join
Ages 12 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosed with type 1 diabetes ≥12 months * Utilize a continuous glucose monitor (CGM) to support diabetes management * Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3 times a day * Are using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration * Cognitively able to participate in incentive program and complete surveys * Have access to a mobile phone to receive information about goal attainment and incentive updates * Have the ability to upload glucose and insulin administration data remotely per processes used by participant's diabetes care team * Caregivers are willing to participate in study and complete surveys Exclusion Criteria: * At time of screening, average CGM wear is greater than 70% of the time or baseline average insulin bolus administration is greater than 3 times a day * Adolescent is not interested in using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration * Cognitively or physically unable to participate * Adolescent is a ward of the state * Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes * Caregivers are not willing to participate in study and complete surveys
About the study
The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes.
Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study. Researchers will compare changes in glucose levels, as well as adolescent and caregiver person-reported outcomes between groups.
What is being tested
- Financial Incentives Program (behavioral)
Sponsor: Harvard Pilgrim Health Care · Participants: 96 · Started: Jun 25, 2024
Contact the study team
- Catherine Pihoker, MD · Phone: 206-987-2637
Official record on ClinicalTrials.gov — NCT06384911
Locations in the U.S.
| Washington | Seattle Children's, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.